Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens
{{output}}
Nafithromycin (WCK 4873) is a novel lactone ketolide antibiotic developed to address the critical issue of multidrug-resistant bacteria, especially those causing community-acquired pneumonia (CAP). Given the increasing prevalence of antibiotic resistance, ther... ...
